8 Recruiting Bladder Cancer Clinical Trials in Texas
Explore active bladder cancer research studies enrolling across Texas. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceRecruiting Bladder Cancer Studies in Texas
🔵 Active, Not Recruiting Phase2 📋 Clinical Research Protocol
Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol
Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research
Genetic Susceptibility to Bladder Cancer
📍 Baylor College of Medicine — Houston, Texas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer
📍 UT Southwestern Medical Center — Dallas, Texas
View Study & Checklist ➔ 🟢 Recruiting Observational / Diagnostic 📋 Clinical Research Protocol
Bladder Cancer Screening Trial
📍 University of Texas Southwestern Medical Center — Dallas, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
📍 Baylor St. Luke's Medical Center — Houston, Texas
View Study & Checklist ➔